Phase I clinical trials demand precision, speed, and airtight supply chains — and VuRoyal Pharmaceutical delivers on all three. From sourcing FDA-recognized reference listed drugs to providing compliant vaccine adjuvants and patient referral partnerships, our end-to-end CRO support is built for sponsors who cannot afford delays, sourcing gaps, or regulatory missteps at the earliest and most critical stage of drug development.
Comprehensive, compliance-driven support services designed to keep your Phase I clinical trial on schedule and on budget.
End-to-end clinical research partnership covering hard-to-source product procurement, analytical testing, trial management, and value-added services — all cost-optimized through proven single-source expertise for Phase I sponsors.
Global procurement and delivery of FDA Orange/Purple Book reference drugs for clinical research, ensuring research-grade quality through compliance-verified partnerships and specialized clinical trial logistics from initial filing through final delivery.
Exclusive supply of GMP-grade QS-21 and Matrix-M™ adjuvants validated in commercial vaccines, with over 20 active Phase I–II trials utilizing these materials across HIV, cancer, Alzheimer's, and other vaccine programs.
Accelerate Phase I enrollment through targeted patient referral partnerships that connect eligible patients with reputable research institutions, hospitals, and clinical investigators — reducing one of the most common sources of trial delay.
Full regulatory compliance support covering imported drug approval registration, import filing, customs clearance, and transportation — backed by our FDA-registered wholesaler status and Massachusetts pharmaceutical licensing.
Specialty cold chain pharmaceutical transportation services for temperature-sensitive investigational products and adjuvants, ensuring product integrity is maintained from international origin through final delivery to your trial site.
Phase I clinical trials are defined by tight timelines and zero tolerance for supply failure. VuRoyal Pharmaceutical — headquartered in Boston and FDA-registered — functions as your single-source CRO partner, bridging the gap between global pharmaceutical supply chains and the precise, documented, compliance-verified product flow your Phase I protocol demands. From reference drug sourcing and customs clearance to GMP-grade adjuvant supply and patient referral acceleration, we eliminate the fragmentation that stalls early-phase trials. Our founders' decades of pharmaceutical R&D experience mean we understand the downstream consequences of every upstream supply decision.
See how VuRoyal has helped research organizations and Phase I sponsors overcome sourcing, logistics, and regulatory hurdles.
VuRoyal brings a rare combination of regulatory standing, global supply chain infrastructure, and deep pharmaceutical R&D roots to every Phase I engagement.
As an FDA-registered, Massachusetts-approved pharmaceutical wholesaler, we meet the compliance standards your Phase I IND demands without additional vetting overhead.
Our end-to-end international procurement network — spanning the U.S., China, and key global markets — ensures hard-to-source Phase I materials arrive on time and fully documented.
Founded by pharmaceutical R&D and clinical research veterans with decades of hands-on experience, we understand Phase I protocols at a scientific level most distributors cannot match.
We provide complimentary regulatory consultation — covering reference preparation selection, import approval registration, and technical guidance — so your team can focus on the science.
Scientific expertise and pharmaceutical industry depth driving every client engagement.
Chief Executive Officer, Ph.D., MPA
Hao Wang leads VuRoyal Pharmaceutical as Chief Executive Officer, bringing advanced academic credentials — a Ph.D. and a Master of Public Administration — together with deep pharmaceutical industry experience. Under his leadership, VuRoyal secured the exclusive partnership with Desert King International in China in October 2023 and has rapidly expanded its influence in both human vaccine adjuvant supply and clinical trial support services. Hao has moderated international scientific forums on vaccine adjuvants, including the inaugural QS-21 Forum held in Shanghai in March 2024 and the 2nd Online Technology Forum on Novel Vaccine Adjuvants in April 2025. His combination of scientific rigor, regulatory understanding, and executive vision positions VuRoyal as a trusted single-source partner for Phase I clinical trial sponsors who require both technical competence and operational reliability at every stage of early-phase drug development.
A Contract Research Organization (CRO) provides outsourced services that support pharmaceutical and biotech companies through clinical development. For Phase I trials, this typically includes investigational product supply and logistics, reference listed drug procurement, regulatory compliance support, patient recruitment and referrals, analytical testing, and trial management — all designed to help sponsors execute trials efficiently while maintaining strict regulatory standards.
Speak directly with our pharmaceutical experts for a no-obligation consultation tailored to your trial.
VuRoyal supports Phase I clinical trial sponsors across the United States, China, and key global markets through our compliant international supply chain.
3+ Regions Served
Global Reach
Boston, MA
Headquarters
International Supply
Availability
Contact our team to confirm supply chain coverage and regulatory capabilities for your location.
Recognized by the FDA as a compliant pharmaceutical wholesaler and exporter.
Certified under drug business quality management standards for pharmaceutical operations.
State-licensed pharmaceutical wholesaler and exporter operating in full regulatory compliance.
Tell us about your Phase I program and supply needs. Our team will respond promptly with a tailored solution — including a free regulatory consultation at no obligation.
For immediate assistance, feel free to give us a direct call at +1 617-870-2690 You can also send us a quick email at
For immediate assistance, feel free to give us a direct call at +1 617-870-2690 You can also send us a quick email at